Skip to content

EBITDA at other companies

Opko Health logo
Opko HealthOPK
-$28.82M+34.0%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$78.09M+6.7%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$52.51M+1,514%
ALN
Alnylam PharmaceuticalsALNY
$282.19M+769%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-$98.33M+16.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+111%
Enterprise value$1.07B+103%
P/S13.5×-1.3×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Calculated from MeiraGTx Holdings plc’s reported figures.

$40.8Mebit+
$3.0MDepreciation Depletion & Amortization
=-$37.81M

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's EBITDA?
MeiraGTx Holdings plc (MGTX) reported EBITDA of -$37.81M in Q1 2026.
How has MeiraGTx Holdings plc's EBITDA changed year-over-year?
MeiraGTx Holdings plc's EBITDA increased by 1.8% year-over-year, from -$38.52M to -$37.81M.
What is the long-term trend for MeiraGTx Holdings plc's EBITDA?
Over 3 years (2021 to 2024), MeiraGTx Holdings plc's EBITDA has grown at a 32.6% compound annual growth rate (CAGR), from -$64.88M to -$151.39M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.